BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang JH, King TM, Chang MC, Hsu CW. Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: Case series analysis. World J Gastroenterol 2012; 18(38): 5427-5433 [PMID: 23082060 DOI: 10.3748/wjg.v18.i38.5427]
URL: https://www.wjgnet.com/1007-9327/full/v18/i38/5427.htm
Number Citing Articles
1
Shingo Miyamoto, Rika Okada, Kazumichi Ando. Platinum hypersensitivity and desensitizationJapanese Journal of Clinical Oncology 2015; 45(9): 795 doi: 10.1093/jjco/hyv081
2
Strauss Gal, Markovits Noa, Margalit Ofer, Halpern Naama, Boursi Ben, Shacham‐Shmueli Einat. Oxaliplatin immune‐mediated thrombocytopenia: Is there a role for premedication or desensitization?British Journal of Clinical Pharmacology 2022; 88(2): 842 doi: 10.1111/bcp.14974
3
Bianca Galateanu, Alexandra Ioana Pușcașu, Simona Andreea Tircol, Bogdan Cosmin Tanase, Ariana Hudita, Carolina Negrei, George-Traian-Alexandru Burcea-Dragomiroiu, Lucian Negreanu, Ileana Adela Vacaroiu, Octav Ginghină. Allergy in Cancer Care: Antineoplastic Therapy-Induced Hypersensitivity ReactionsInternational Journal of Molecular Sciences 2023; 24(4): 3886 doi: 10.3390/ijms24043886
4
Baojiang Liu, Song Gao, Jianhai Guo, Fuxin Kou, Shaoxing Liu, Xin Zhang, Aiwei Feng, Xiaodong Wang, Guang Cao, Liang Xu, Hui Chen, Peng Liu, Haifeng Xu, Qinzong Gao, Renjie Yang, Xu Zhu. High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapyInternational Immunopharmacology 2024; 130: 111767 doi: 10.1016/j.intimp.2024.111767
5
Shu-Ping Jiang, Zhen-Dong Zhang, Lu-Mei Kang, Qing-Hua Wang, Lei Zhang, Hong-Ping Chen. Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglionExperimental Neurology 2016; 275: 11 doi: 10.1016/j.expneurol.2015.11.001
6
Francesca Aroldi, Tiziana Prochilo, Paola Bertocchi, Alberto Zaniboni. Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and managementJournal of Chemotherapy 2015; 27(2): 63 doi: 10.1179/1973947814Y.0000000204
7
Justine Pasteur, Laure Favier, Corinne Pernot, Mathieu Guerriaud, Charlotte Bernigaud, Côme Lepage, Jean-Louis Jouve, Nicolas Isambert, Evelyne Collet. Low Cross-Reactivity Between Cisplatin and Other Platinum SaltsThe Journal of Allergy and Clinical Immunology: In Practice 2019; 7(6): 1894 doi: 10.1016/j.jaip.2019.01.057
8
Ying Zhao, Shusen Sun, Xiaotong Li, Xiang Ma, Huilin Tang, Lulu Sun, Suodi Zhai, Tiansheng Wang. Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance DatabaseInternational Journal of Clinical Pharmacy 2018; 40(5): 1349 doi: 10.1007/s11096-017-0535-2
9
OxaliplatinReactions Weekly 2014; 1495(1): 36 doi: 10.1007/s40278-014-9965-y
10
Zaoqin Yu, Rui Huang, Li Zhao, Ximin Wang, Xiaofang Shangguan, Wei Li, Min Li, Xianguo Yin, Chengliang Zhang, Dong Liu. Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance StudyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.757196
11
Joana Caiado, Matthieu Picard. Diagnostic Tools for Hypersensitivity to Platinum Drugs and Taxanes: Skin Testing, Specific IgE, and Mast Cell/Basophil MediatorsCurrent Allergy and Asthma Reports 2014; 14(8) doi: 10.1007/s11882-014-0451-7
12
Hiroyuki Koami, Yuichiro Sakamoto, Takashi Furukawa, Hisashi Imahase, Takashi Iwamura, Satoshi Inoue. Utility of rotational thromboelastometry for the diagnosis of asymptomatic hyperfibrinolysis secondary to anaphylaxisBlood Coagulation & Fibrinolysis 2016; 27(4): 450 doi: 10.1097/MBC.0000000000000441
13
Nusrat Bano, Rahila Najam, Faaiza Qazi, Ahmed Mateen. Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic ApproachesAsian Pacific Journal of Cancer Prevention 2016; 17(4): 1637 doi: 10.7314/APJCP.2016.17.4.1637
14
Guranjan D. Grewal, Timothy C. Badrick, Peter J. Gilbar. Immediate and Delayed Hypersensitivity Reactions to a Single Dose of OxaliplatinClinical Colorectal Cancer 2015; 14(2): 128 doi: 10.1016/j.clcc.2014.12.010
15
Mohammad Azhar Aziz, Zeyad Yousef, Ayman M. Saleh, Sameer Mohammad, Bandar Al Knawy. Towards personalized medicine of colorectal cancerCritical Reviews in Oncology/Hematology 2017; 118: 70 doi: 10.1016/j.critrevonc.2017.08.007